시장보고서

상품코드

1671083

화학발광 면역측정법 시장 : 시장 규모, 점유율, 동향, 산업 분석 보고서 - 제품 유형별, 샘플 유형별, 기술별, 용도별, 지역별 시장 예측(2025-2034년)

Chemiluminescence Immunoassay Market Size, Share, Trends, Industry Analysis Report: By Product, Sample Type, Technology, Application, and Region - Market Forecast, 2025-2034

발행일: 2025년 02월 | 리서치사:

Polaris Market Research | 페이지 정보: 영문 116 Pages | 배송안내 : 1-2일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

Polaris Market Research의 최근 조사에 따르면 화학발광 면역측정법 시장 규모는 2034년까지 189억 7,000만 달러에 달할 전망입니다. 이 설문조사 보고서는 현재 시장 역학을 자세히 파악하고 향후 시장 성장에 대한 분석을 제공합니다.

화학발광 면역측정법(CLIA) 시장의 성장은 정확하고 효율적인 고감도 진단 솔루션에 대한 수요 증가로 인한 것입니다. 시장 성장의 주요 촉진요인으로는 만성 질환 및 감염의 유행 증가, 질병의 조기 발견 필요성, 맞춤형 의료에 대한 관심 증가 등이 있습니다. CLIA 시장 기회는 자동화, AI 통합, 멀티플렉스 분석 개발 등의 기술적 진보에 의해 촉진됩니다. 포인트 오브 케어 검사의 확대, 비침습적 샘플 유형으로의 이동, 디지털 플랫폼의 채용 확대 등의 동향은 시장의 성장을 더욱 뒷받침합니다. 신흥국의 헬스케어 인프라가 개선되고 새로운 성장의 길이 열리면서 시장은 향후 수년간 확대될 것으로 예상됩니다.

화학발광 면역측정법 시장 보고서 하이라이트

진단 검사에 사용 빈도가 높기 때문에 제품별로 시약 부문이 화학발광 면역측정법 시장 점유율을 독점하고 있습니다. 소모품 부문은 검사실 및 포인트 오브 케어에서 카트리지 및 마이크로플레이트와 같은 일회용 아이템의 채용 증가로 인해 가장 높은 성장이 예상됩니다.

샘플 유형별로, 혈액 샘플 분야는 신뢰성과 다양한 의료 검사에 대한 광범위한 적용으로 시장에서 가장 큰 점유율을 차지합니다. 타액 기반 검사는 비 침습적 성질과 COVID-19 및 호르몬 검사와 같은 질병 진단에 사용이 증가함에 따라 가장 급성장하는 분야입니다.

기술별로는 전기 화학발광 면역측정법(ECLIA) 분야가 특히 저분석물 농도의 검출에 있어서 높은 감도와 정밀도를 가지기 때문에 최대 시장 점유율을 차지하고 있습니다. 미립자 화학발광 면역분석(MCLIA) 분야는 특히 높은 처리량 환경에서 감도 향상과 분석 시간 단축이 가능하기 때문에 급성장이 예상됩니다.

정확하고 신속한 진단 검사에 대한 세계 수요의 높이에서 용도별로는 감염증 분야가 CLIA 시장의 매출 점유율을 독점하고 있습니다. 암 분야는 암 이환율의 상승과 종양 마커의 검출과 모니터링에 있어서의 CLIA 검정의 사용 증가에 의해 가장 높은 성장이 전망되고 있습니다.

북미는 첨단 의료 인프라, CLIA 시스템의 높은 보급률 및 진단에 대한 대규모 투자로 화학발광 면역측정법(CLIA) 시장을 선도하고 있습니다. 아시아태평양은 의료 접근의 확대, 만성 질환 및 감염의 유행, 중국과 인도와 같은 신흥 시장의 의료비 증가로 인해 가장 성장하는 지역입니다.

시장 현황
화학발광 면역측정법 시장 역학
- 성장 촉진요인 및 기회
  - 자동화 및 디지털 기술의 통합
  - 포인트 오브 케어 검사의 도입 증가
- 성장 억제요인 및 과제
  - 엄격한 생산 기준
PESTEL 분석
화학발광 면역측정법 시장 동향
밸류체인 분석

제5장 세계의 화학발광 면역측정법 시장 : 제품별

주요 조사 결과
서문
기기
소모품
시약
기타

제6장 세계의 화학발광 면역측정법 시장 : 샘플 유형별

주요 조사 결과
서문
피
소변
타액
기타

제7장 세계의 화학발광 면역측정법 시장 : 기술별

주요 조사 결과
서문
화학발광 효소 기술
전기 화학발광 면역측정법
미립자 화학발광 면역측정법

제8장 세계의 화학발광 면역측정법 시장 : 용도별

주요 조사 결과
서문
치료제 모니터링
종양학
심장병학
내분비학
감염증

제9장 세계의 화학발광 면역측정법 시장 : 지역

주요 조사 결과
서문
- 화학발광 면역측정법 시장의 평가 : 지역별(2020-2034년)
북미
- 북미 : 제품별(2020-2034년)
- 북미 : 샘플 유형별(2020-2034년)
- 북미 : 기술별(2020-2034년)
- 북미 : 용도별(2020-2034년)
- 미국
- 캐나다
유럽
- 유럽 : 제품별(2020-2034년)
- 유럽 : 샘플 유형별(2020-2034년)
- 유럽 : 기술별(2020-2034년)
- 유럽 : 용도별(2020-2034년)
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
아시아태평양
- 아시아태평양 : 제품별(2020-2034년)
- 아시아태평양 : 샘플 유형별(2020-2034년)
- 아시아태평양 : 기술별(2020-2034년)
- 아시아태평양 : 용도별(2020-2034년)
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
중동 및 아프리카
- 중동 및 아프리카 : 제품별(2020-2034년)
- 중동 및 아프리카 : 샘플 유형별(2020-2034년)
- 중동 및 아프리카 : 기술별(2020-2034년)
- 중동 및 아프리카 : 용도별(2020-2034년)
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카
- 기타 중동 및 아프리카
라틴아메리카
- 라틴아메리카 : 제품별(2020-2034년)
- 라틴아메리카 : 샘플 유형별(2020-2034년)
- 라틴아메리카 : 기술별(2020-2034년)
- 라틴아메리카 : 용도별(2020-2034년)
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카

제10장 경쟁 구도

확대 및 인수 분석
- 확대
- 인수
제휴, 협업, 합의 및 공개

제11장 기업 프로파일

Abbott Laboratories
Beckman Coulter
Biokit
BioMerieux
DiaSorin
Fujirebio Diagnostics
Mindray Medical International
Ortho Clinical Diagnostics
Siemens Healthineers
Tosoh Corporation
Sysmex Corporation

AJY 25.03.25

The chemiluminescence immunoassay market size is expected to reach USD 18.97 billion by 2034, according to a new study by Polaris Market Research. The report "Chemiluminescence Immunoassay Market Size, Share, Trends, Industry Analysis Report: By Product (Instruments, Consumables, Reagents, and Others), Sample Type (Blood, Urine, Saliva, and Others), Technology, Application, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The chemiluminescence immunoassay (CLIA) market growth is attributed to the increasing demand for accurate, efficient, and high-sensitivity diagnostic solutions. A few key drivers of the market growth are the rising prevalence of chronic and infectious diseases, the need for early disease detection, and the growing focus on personalized medicine. CLIA market opportunities are fueled by technological advancements such as automation, AI integration, and the development of multiplex assays. Trends such as the expansion of point-of-care testing, the shift toward noninvasive sample types, and the growing adoption of digital platforms further support market growth. The market is expected to expand in the coming years as healthcare infrastructure improves in emerging economies, providing new avenues for growth.

Chemiluminescence Immunoassay Market Report Highlights

The reagents segment, based on product, dominates the chemiluminescence immunoassay market share due to their frequent usage in diagnostic tests. The consumables segment is expected to register the highest growth, driven by the increasing adoption of disposable items such as cartridges and microplates in laboratories and point-of-care settings.

By sample type, the blood sample segment holds the largest share of the market due to its reliability and wide application in various medical tests. Saliva-based testing is the fastest-growing segment, driven by its noninvasive nature and increasing use in disease diagnostics such as COVID-19 and hormonal tests.

The electrochemiluminescence Immunoassay (ECLIA) segment, by technology, holds the largest market share due to its high sensitivity and precision, particularly in detecting low analyte concentrations. The microparticle chemiluminescence immunoassay (MCLIA) segment is expected to grow the fastest, driven by its ability to increase sensitivity and reduce assay times, particularly in high-throughput environments.

The infectious diseases segment, based on application, dominates the CLIA market revenue share due to the high global demand for accurate, rapid diagnostic tests. The oncology segment is expected to witness the highest growth, fueled by the rising incidence of cancer and increasing use of CLIA assays in tumor marker detection and monitoring.

North America leads the chemiluminescence immunoassay (CLIA) market due to its advanced healthcare infrastructure, high adoption of CLIA systems, and large investments in diagnostics. Asia Pacific is the highest growing region, driven by expanding healthcare access, rising chronic and infectious disease prevalence, and increasing healthcare expenditures in emerging markets such as China and India.

Polaris Market Research has segmented the chemiluminescence immunoassay market report on the basis of product, sample type, technology, application, and region:

By Product Outlook (Revenue - USD Billion, 2020 - 2034)

Instruments
Consumables
Reagents
Others

By Sample Type Outlook (Revenue - USD Billion, 2020 - 2034)

Blood
Urine
Saliva
Others

By Technology Outlook (Revenue - USD Billion, 2020 - 2034)

Chemiluminescence Enzyme Technology
Electrochemiluminescence Immunoassay
Microparticle Chemiluminescence Immunoassay

By Application Outlook (Revenue - USD Billion, 2020 - 2034)

Therapeutic Drug Monitoring
Oncology
Cardiology
Endocrinology
Infectious Diseases

By Regional Outlook (Revenue - USD Billion, 2020 - 2034)

North America
US
Canada
Europe
Germany
France
UK
Italy
Spain
Netherlands
Russia
Rest of Europe
Asia Pacific
China
Japan
India
Malaysia
South Korea
Indonesia
Australia
Vietnam
Rest of Asia Pacific
Middle East & Africa
Saudi Arabia
UAE
Israel
South Africa
Rest of Middle East & Africa
Latin America
Mexico
Brazil
Argentina
Rest of Latin America

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Source
- 3.2.1. Primary Source
- 3.2.2. Secondary Source

4. Global Chemiluminescence Immunoassay Market Insights

4.1. Chemiluminescence Immunoassay Market - Market Snapshot
4.2. Chemiluminescence Immunoassay Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Integration of automation and digital technologies
  - 4.2.1.2. Rising adoption of point-of-care testing
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. Strict production norms
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Chemiluminescence Immunoassay Market Trends
4.6. Value Chain Analysis

5. Global Chemiluminescence Immunoassay Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
5.3. Instruments
- 5.3.1. Global Chemiluminescence Immunoassay Market, by Instruments, by Region, 2020-2034 (USD Billion)
5.4. Consumables
- 5.4.1. Global Chemiluminescence Immunoassay Market, by Consumables, by Region, 2020-2034 (USD Billion)
5.5. Reagents
- 5.5.1. Global Chemiluminescence Immunoassay Market, by Reagents, by Region, 2020-2034 (USD Billion)
5.6. Other
- 5.6.1. Global Chemiluminescence Immunoassay Market, by Other, by Region, 2020-2034 (USD Billion)

6. Global Chemiluminescence Immunoassay Market, by Sample Type

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
6.3. Blood
- 6.3.1. Global Chemiluminescence Immunoassay Market, by Blood, by Region, 2020-2034 (USD Billion)
6.4. Urine
- 6.4.1. Global Chemiluminescence Immunoassay Market, by Urine, by Region, 2020-2034 (USD Billion)
6.5. Saliva
- 6.5.1. Global Chemiluminescence Immunoassay Market, by Saliva, by Region, 2020-2034 (USD Billion)
6.6. Others
- 6.6.1. Global Chemiluminescence Immunoassay Market, by Others, by Region, 2020-2034 (USD Billion)

7. Global Chemiluminescence Immunoassay Market, by Technology

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
7.3. Chemiluminescence Enzyme Technology
- 7.3.1. Global Chemiluminescence Immunoassay Market, by Chemiluminescence Enzyme Technology, by Region, 2020-2034 (USD Billion)
7.4. Electrochemiluminescence Immunoassay
- 7.4.1. Global Chemiluminescence Immunoassay Market, by Electrochemiluminescence Immunoassay, by Region, 2020-2034 (USD Billion)
7.5. Microparticle Chemiluminescence Immunoassay
- 7.5.1. Global Chemiluminescence Immunoassay Market, by Microparticle Chemiluminescence Immunoassay, by Region, 2020-2034 (USD Billion)

8. Global Chemiluminescence Immunoassay Market, by Application

8.1. Key Findings
8.2. Introduction
- 8.2.1. Global Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
8.3. Therapeutic Drug Monitoring
- 8.3.1. Global Chemiluminescence Immunoassay Market, by Therapeutic Drug Monitoring, by Region, 2020-2034 (USD Billion)
8.4. Oncology
- 8.4.1. Global Chemiluminescence Immunoassay Market, by Oncology, by Region, 2020-2034 (USD Billion)
8.5. Cardiology
- 8.5.1. Global Chemiluminescence Immunoassay Market, by Cardiology, by Region, 2020-2034 (USD Billion)
8.6. Endocrinology
- 8.6.1. Global Chemiluminescence Immunoassay Market, by Endocrinology, by Region, 2020-2034 (USD Billion)
8.7. Infectious diseases
- 8.7.1. Global Chemiluminescence Immunoassay Market, by Infectious diseases, by Region, 2020-2034 (USD Billion)

9. Global Chemiluminescence Immunoassay Market, by Geography

9.1. Key Findings
9.2. Introduction
- 9.2.1. Chemiluminescence Immunoassay Market Assessment, By Geography, 2020-2034 (USD Billion)
9.3. Chemiluminescence Immunoassay Market - North America
- 9.3.1. North America: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
- 9.3.2. North America: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
- 9.3.3. North America: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
- 9.3.4. North America: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.3.5. Chemiluminescence Immunoassay Market - US
  - 9.3.5.1. US: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.3.5.2. US: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.3.5.3. US: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.3.5.4. US: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.3.6. Chemiluminescence Immunoassay Market - Canada
  - 9.3.6.1. Canada: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.3.6.2. Canada: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.3.6.3. Canada: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.3.6.4. Canada: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
9.4. Chemiluminescence Immunoassay Market - Europe
- 9.4.1. Europe: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
- 9.4.2. Europe: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
- 9.4.3. Europe: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
- 9.4.4. Europe: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.5. Chemiluminescence Immunoassay Market - UK
  - 9.4.5.1. UK: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.5.2. UK: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.5.3. UK: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.5.4. UK: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.6. Chemiluminescence Immunoassay Market - France
  - 9.4.6.1. France: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.6.2. France: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.6.3. France: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.6.4. France: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.7. Chemiluminescence Immunoassay Market - Germany
  - 9.4.7.1. Germany: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.7.2. Germany: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.7.3. Germany: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.7.4. Germany: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.8. Chemiluminescence Immunoassay Market - Italy
  - 9.4.8.1. Italy: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.8.2. Italy: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.8.3. Italy: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.8.4. Italy: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.9. Chemiluminescence Immunoassay Market - Spain
  - 9.4.9.1. Spain: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.9.2. Spain: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.9.3. Spain: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.9.4. Spain: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.10. Chemiluminescence Immunoassay Market - Netherlands
  - 9.4.10.1. Netherlands: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.10.2. Netherlands: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.10.3. Netherlands: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.10.4. Netherlands: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.11. Chemiluminescence Immunoassay Market - Russia
  - 9.4.11.1. Russia: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.11.2. Russia: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.11.3. Russia: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.11.4. Russia: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.4.12. Chemiluminescence Immunoassay Market - Rest of Europe
  - 9.4.12.1. Rest of Europe: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.4.12.2. Rest of Europe: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.4.12.3. Rest of Europe: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.4.12.4. Rest of Europe: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
9.5. Chemiluminescence Immunoassay Market - Asia Pacific
- 9.5.1. Asia Pacific: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
- 9.5.2. Asia Pacific: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
- 9.5.3. Asia Pacific: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
- 9.5.4. Asia Pacific: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.5. Chemiluminescence Immunoassay Market - China
  - 9.5.5.1. China: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.5.2. China: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.5.3. China: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.5.4. China: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.6. Chemiluminescence Immunoassay Market - India
  - 9.5.6.1. India: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.6.2. India: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.6.3. India: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.6.4. India: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.7. Chemiluminescence Immunoassay Market - Malaysia
  - 9.5.7.1. Malaysia: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.7.2. Malaysia: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.7.3. Malaysia: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.7.4. Malaysia: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.8. Chemiluminescence Immunoassay Market - Japan
  - 9.5.8.1. Japan: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.8.2. Japan: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.8.3. Japan: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.8.4. Japan: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.9. Chemiluminescence Immunoassay Market - Indonesia
  - 9.5.9.1. Indonesia: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.9.2. Indonesia: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.9.3. Indonesia: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.9.4. Indonesia: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.10. Chemiluminescence Immunoassay Market - South Korea
  - 9.5.10.1. South Korea: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.10.2. South Korea: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.10.3. South Korea: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.10.4. South Korea: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.11. Chemiluminescence Immunoassay Market - Australia
  - 9.5.11.1. Australia: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.11.2. Australia: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.11.3. Australia: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.11.4. Australia: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.5.12. Chemiluminescence Immunoassay Market - Rest of Asia Pacific
  - 9.5.12.1. Rest of Asia Pacific: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.5.12.2. Rest of Asia Pacific: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.5.12.3. Rest of Asia Pacific: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.5.12.4. Rest of Asia Pacific: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
9.6. Chemiluminescence Immunoassay Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
- 9.6.2. Middle East & Africa: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
- 9.6.3. Middle East & Africa: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
- 9.6.4. Middle East & Africa: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.6.5. Chemiluminescence Immunoassay Market - Saudi Arabia
  - 9.6.5.1. Saudi Arabia: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.6.5.2. Saudi Arabia: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.5.3. Saudi Arabia: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.6.5.4. Saudi Arabia: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.6.6. Chemiluminescence Immunoassay Market - UAE
  - 9.6.6.1. UAE: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.6.6.2. UAE: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.6.3. UAE: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.6.6.4. UAE: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.6.7. Chemiluminescence Immunoassay Market - Israel
  - 9.6.7.1. Israel: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.6.7.2. Israel: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.7.3. Israel: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.6.7.4. Israel: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.6.8. Chemiluminescence Immunoassay Market - South Africa
  - 9.6.8.1. South Africa: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.6.8.2. South Africa: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.8.3. South Africa: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.6.8.4. South Africa: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.6.9. Chemiluminescence Immunoassay Market - Rest of Middle East & Africa
  - 9.6.9.1. Rest of Middle East & Africa: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.6.9.2. Rest of Middle East & Africa: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.6.9.3. Rest of Middle East & Africa: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.6.9.4. Rest of Middle East & Africa: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
9.7. Chemiluminescence Immunoassay Market - Latin America
- 9.7.1. Latin America: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
- 9.7.2. Latin America: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
- 9.7.3. Latin America: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
- 9.7.4. Latin America: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.7.5. Chemiluminescence Immunoassay Market - Mexico
  - 9.7.5.1. Mexico: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.7.5.2. Mexico: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.5.3. Mexico: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.7.5.4. Mexico: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.7.6. Chemiluminescence Immunoassay Market - Brazil
  - 9.7.6.1. Brazil: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.7.6.2. Brazil: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.6.3. Brazil: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.7.6.4. Brazil: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.7.7. Chemiluminescence Immunoassay Market - Argentina
  - 9.7.7.1. Argentina: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.7.7.2. Argentina: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.7.3. Argentina: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.7.7.4. Argentina: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)
- 9.7.8. Chemiluminescence Immunoassay Market - Rest of Latin America
  - 9.7.8.1. Rest of Latin America: Chemiluminescence Immunoassay Market, by Product, 2020-2034 (USD Billion)
  - 9.7.8.2. Rest of Latin America: Chemiluminescence Immunoassay Market, by Sample Type, 2020-2034 (USD Billion)
  - 9.7.8.3. Rest of Latin America: Chemiluminescence Immunoassay Market, by Technology, 2020-2034 (USD Billion)
  - 9.7.8.4. Rest of Latin America: Chemiluminescence Immunoassay Market, by Application, 2020-2034 (USD Billion)

10. Competitive Landscape

10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
10.2. Partnerships/Collaborations/Agreements/Exhibitions

11. Company Profiles

11.1. Abbott Laboratories
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
11.2. Beckman Coulter
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
11.3. Biokit
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
11.4. BioMerieux
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
11.5. DiaSorin
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
11.6. Fujirebio Diagnostics
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
11.7. Mindray Medical International
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
11.8. Ortho Clinical Diagnostics
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
11.9. Siemens Healthineers
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
11.10. Tosoh Corporation
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
11.11. Sysmex Corporation
- 11.11.1. Company Overview
- 11.11.2. Financial Performance
- 11.11.3. Product Benchmarking
- 11.11.4. Recent Development